{"transactions":[{"id":739354,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2026-06-12T11:42:23.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":50500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":50500,"derivative":{"exercise_price":3.99,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":50500},"source":{"system":"sec-edgar","filing":"0001214659-26-007395","document":"marketforms-73381.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1373585/000121465926007395/marketforms-73381.xml","form_type":"4"}},{"id":940458,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:03:44.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":30456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 30,456 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,456 unvested restricted stock units."}],"balance_after":95659,"source":{"system":"sec-edgar","filing":"0001373585-26-000003","document":"wk-form4_1768338222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000137358526000003/wk-form4_1768338222.xml","form_type":"4"}},{"id":1112983,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-06-12T14:13:31.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":3.41,"value":143220.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":42000,"derivative":{"exercise_price":3.41,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001214659-25-009128","document":"marketforms-69477.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1373585/000121465925009128/marketforms-69477.xml","form_type":"4"}},{"id":1304647,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-13T21:06:10.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":15789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 15,789 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,789 unvested restricted stock units."}],"balance_after":65203,"source":{"system":"sec-edgar","filing":"0001373585-25-000002","document":"wk-form4_1736802363.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000137358525000002/wk-form4_1736802363.xml","form_type":"4"}},{"id":1471802,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2024-06-21T13:51:01.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":38000,"derivative":{"exercise_price":2.5,"exercise_date":"2025-06-20","expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001214659-24-011219","document":"marketforms-66323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1373585/000121465924011219/marketforms-66323.xml","form_type":"4"}},{"id":1681152,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-11T21:04:22.000Z","date":"2024-01-09","kind":"grant","planned":false,"acquired":true,"shares":19480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 19,480 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 19,480 unvested restricted stock units."}],"balance_after":49414,"source":{"system":"sec-edgar","filing":"0001373585-24-000002","document":"wk-form4_1705007053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000137358524000002/wk-form4_1705007053.xml","form_type":"4"}},{"id":1844943,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-06-23T13:41:23.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.02,"exercise_date":"2024-06-21","expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-23-008799","document":"marketforms-61958.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1373585/000121465923008799/marketforms-61958.xml","form_type":"4"}},{"id":2057067,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-11T21:13:54.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 20,000 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,362 unvested restricted stock units."}],"balance_after":29934,"source":{"system":"sec-edgar","filing":"0001373585-23-000004","document":"wf-form4_167347161752987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000137358523000004/wf-form4_167347161752987.xml","form_type":"4"}},{"id":2221896,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2022-06-24T17:02:41.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 22, 2023, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.7132,"exercise_date":"2023-06-22","expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-22-008292","document":"marketforms-56514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1373585/000121465922008292/marketforms-56514.xml","form_type":"4"}},{"id":2437209,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-12T21:06:31.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":65430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 65,430 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 10, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 103,165 unvested restricted stock units."}],"balance_after":149040,"source":{"system":"sec-edgar","filing":"0001373585-22-000002","document":"wf-form4_164202157345903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000137358522000002/wf-form4_164202157345903.xml","form_type":"4"}},{"id":2660321,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-06-21T16:05:21.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 15, 2022, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":4.04,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001214659-21-006757","document":"marketforms-53152.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1373585/000121465921006757/marketforms-53152.xml","form_type":"4"}},{"id":2910140,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-12T23:14:55.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":37735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 37,735 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 11, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 56,027 unvested restricted stock units."}],"balance_after":83610,"source":{"system":"sec-edgar","filing":"0001373585-21-000003","document":"wf-form4_161049328096383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000137358521000003/wf-form4_161049328096383.xml","form_type":"4"}},{"id":3105155,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-06-18T17:12:56.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 16, 2021, subject to Mr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":14000,"derivative":{"exercise_price":5.3,"exercise_date":"2021-06-16","expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001214659-20-005776","document":"marketforms-49051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1373585/000121465920005776/marketforms-49051.xml","form_type":"4"}},{"id":3312124,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-01-14T21:13:30.000Z","date":"2020-01-13","kind":"grant","acquired":true,"shares":18292,"price":3.28,"value":59997.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 18,292 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 13, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,292 unvested restricted stock units."}],"balance_after":45875,"source":{"system":"sec-edgar","filing":"0001373585-20-000002","document":"wf-form4_157903639231877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000137358520000002/wf-form4_157903639231877.xml","form_type":"4"}},{"id":3351566,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:32:17.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":2766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":40.06,"underlying":"Common Stock","underlying_shares":2766},"source":{"system":"sec-edgar","filing":"0001209191-19-059238","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059238/doc4.xml","form_type":"4"}},{"id":3351565,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:32:17.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":1980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":53.7,"underlying":"Common Stock","underlying_shares":1980},"source":{"system":"sec-edgar","filing":"0001209191-19-059238","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059238/doc4.xml","form_type":"4"}},{"id":3351564,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:32:17.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":44.225,"underlying":"Common Stock","underlying_shares":360},"source":{"system":"sec-edgar","filing":"0001209191-19-059238","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059238/doc4.xml","form_type":"4"}},{"id":3351563,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T13:32:17.000Z","date":"2019-12-04","kind":"sale","acquired":false,"shares":9015,"price":60,"value":540900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of for $60.00 per share pursuant to the terms of that certain Agreement and Plan of Merger dated as of August 7, 2019, by and among Catalog Intermediate Inc. (\"Parent\"), Catalog Merger Sub (\"Merger Sub\"), each entities controlled by investment funds advised by Permira Advisors LLC, and the Company (the \"Merger Agreement\").  All terms capitalized but not defined shall have the respective meanings given to them in the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-059238","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059238/doc4.xml","form_type":"4"}},{"id":3351562,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T13:32:17.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":2766,"price":40.06,"value":110805.96,"ownership":{"direct":true},"balance_after":9015,"source":{"system":"sec-edgar","filing":"0001209191-19-059238","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059238/doc4.xml","form_type":"4"}},{"id":3351561,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T13:32:17.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":1980,"price":53.7,"value":106326.0,"ownership":{"direct":true},"balance_after":6249,"source":{"system":"sec-edgar","filing":"0001209191-19-059238","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059238/doc4.xml","form_type":"4"}},{"id":3351560,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T13:32:17.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":360,"price":44.225,"value":15921.0,"ownership":{"direct":true},"balance_after":4269,"source":{"system":"sec-edgar","filing":"0001209191-19-059238","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059238/doc4.xml","form_type":"4"}},{"id":3487402,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-06-17T21:42:00.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":13350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 13, 2020, subject to Mr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":13350,"derivative":{"exercise_price":4.38,"exercise_date":"2020-06-13","expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":13350},"source":{"system":"sec-edgar","filing":"0001214659-19-004250","document":"marketforms-45220.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1373585/000121465919004250/marketforms-45220.xml","form_type":"4"}},{"id":3549434,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-25T20:33:50.000Z","date":"2019-04-24","kind":"grant","acquired":true,"shares":2766,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2766,"derivative":{"exercise_price":40.06,"exercise_date":"2019-10-24","expiration_date":"2026-04-23","underlying":"Common Stock","underlying_shares":2766},"source":{"system":"sec-edgar","filing":"0001209191-19-026059","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119026059/doc4.xml","form_type":"4"}},{"id":3549433,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-25T20:33:50.000Z","date":"2019-04-24","kind":"grant","acquired":true,"shares":2247,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3909,"source":{"system":"sec-edgar","filing":"0001209191-19-026059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119026059/doc4.xml","form_type":"4"}},{"id":3695042,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-01-16T21:02:16.000Z","date":"2019-01-14","kind":"grant","acquired":true,"shares":12121,"price":4.95,"value":59998.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 12,121 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 14, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,121 unvested restricted stock units."}],"balance_after":27583,"source":{"system":"sec-edgar","filing":"0001373585-19-000013","document":"wf-form4_154767252002651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000137358519000013/wf-form4_154767252002651.xml","form_type":"4"}},{"id":3698599,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-10T17:10:05.000Z","date":"2019-01-08","kind":"grant","acquired":true,"shares":8747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 8,747 shares underlying restricted stock granted under the 2018 Equity Incentive Compensation Plan which were awarded on January 8, 2018 and which vested on January 8, 2019."}],"balance_after":15462,"source":{"system":"sec-edgar","filing":"0001373585-19-000010","document":"wf-form4_154714018596063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000137358519000010/wf-form4_154714018596063.xml","form_type":"4"}},{"id":3860712,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-07-26T21:09:18.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 25% of the underlying shares vest on the first anniversary of the grant date, 25% of the underlying shares vest on the second anniversary of the grant date and the remaining 50% of the underlying shares vest on the third anniversary of the grant date, subject in each case to Mr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":26700,"derivative":{"exercise_price":15,"expiration_date":"2028-07-24","underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001140361-18-033740","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1373585/000114036118033740/form4.xml","form_type":"4"}},{"id":3954132,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-04-30T20:43:00.000Z","date":"2018-04-26","kind":"grant","acquired":true,"shares":1980,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1980,"derivative":{"exercise_price":53.7,"exercise_date":"2018-10-26","expiration_date":"2025-04-25","underlying":"Common Stock","underlying_shares":1980},"source":{"system":"sec-edgar","filing":"0001209191-18-026941","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118026941/doc4.xml","form_type":"4"}},{"id":3954131,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-30T20:43:00.000Z","date":"2018-04-26","kind":"grant","acquired":true,"shares":1397,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1662,"source":{"system":"sec-edgar","filing":"0001209191-18-026941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118026941/doc4.xml","form_type":"4"}},{"id":4102467,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-01-10T21:05:30.000Z","date":"2018-01-08","kind":"grant","acquired":true,"shares":8747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on the date that is one year from the date of grant."}],"balance_after":8747,"derivative":{"exercise_date":"2019-01-08","expiration_date":"2028-01-08","underlying":"Common Stock","underlying_shares":8747},"source":{"system":"sec-edgar","filing":"0001144204-18-001697","document":"tv483049_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420418001697/tv483049_4.xml","form_type":"4"}},{"id":4175526,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2017-11-02T16:25:25.000Z","date":"2017-10-31","kind":"grant","acquired":true,"shares":360,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":360,"derivative":{"exercise_price":44.225,"exercise_date":"2018-04-30","expiration_date":"2024-10-31","underlying":"Common Stock","underlying_shares":360},"source":{"system":"sec-edgar","filing":"0001437749-17-018158","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774917018158/rdgdoc.xml","form_type":"4"}},{"id":4175525,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-11-02T16:25:25.000Z","date":"2017-10-31","kind":"grant","acquired":true,"shares":265,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":265,"source":{"system":"sec-edgar","filing":"0001437749-17-018158","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774917018158/rdgdoc.xml","form_type":"4"}},{"id":4314547,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-18T21:01:15.000Z","date":"2017-05-16","kind":"grant","acquired":true,"shares":2565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 2,565 Restricted Stock Units granted under the Issuer's 2015 Equity Compensation Plan that will vest on May 16, 2018. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest over a three-year period beginning on October 10, 2017, 1,650 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on January 9, 2018 and 2,565 shares of unvested Restricted Stock Units granted under the Issuer's 2015 Equity Compensation Plan that will vest on May 16, 2018."}],"balance_after":6715,"source":{"system":"sec-edgar","filing":"0001144204-17-028455","document":"v467410_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417028455/v467410_4.xml","form_type":"4"}},{"id":4476244,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2017-01-31T23:49:54.000Z","date":"2017-01-09","kind":"grant","acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2750,"derivative":{"exercise_price":3.54,"exercise_date":"2018-01-09","expiration_date":"2027-01-09","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001144204-17-005180","document":"v457998_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417005180/v457998_4.xml","form_type":"4"}},{"id":4476243,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-31T23:49:54.000Z","date":"2017-01-09","kind":"grant","acquired":true,"shares":1650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 1,650 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on January 9, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,150 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan."}],"balance_after":4150,"source":{"system":"sec-edgar","filing":"0001144204-17-005180","document":"v457998_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417005180/v457998_4.xml","form_type":"4"}},{"id":4581027,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-10-12T13:06:47.000Z","date":"2016-10-10","kind":"grant","acquired":true,"shares":4150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This grant was made in connection with the Reporting Person's appointment to the Issuer's board of directors, audit committee and nominating and corporate governance committee."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest in equal annual installments over a three-year period, commencing on the first anniversary of the grant date."}],"balance_after":4150,"derivative":{"exercise_price":4.66,"exercise_date":"2017-10-10","expiration_date":"2026-10-10","underlying":"Common Stock","underlying_shares":4150},"source":{"system":"sec-edgar","filing":"0001144204-16-127776","document":"v450347_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420416127776/v450347_4.xml","form_type":"4"}},{"id":4581026,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-12T13:06:47.000Z","date":"2016-10-10","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This grant was made in connection with the Reporting Person's appointment to the Issuer's board of directors, audit committee and nominating and corporate governance committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 2,500 shares of restricted stock that will vest in equal annual installments over a three-year period, commencing on the first anniversary of the grant date."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-16-127776","document":"v450347_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420416127776/v450347_4.xml","form_type":"4"}}]}